CD109 and hepatocellular carcinoma: Moreover, reduced expression of CD109 on hepatocellular carcinoma tumor vessels is associated with large tumor size, microvascular invasion, and advanced tumor stage and CD109 is an independent risk factor for disease-free survival (P = 0.001)34.